Decitabine Intravenous and Insulin lispro Subcutaneous
Determining the interaction of Decitabine Intravenous and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: decitabine
Brand name: Dacogen
Synonyms: Decitabine
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Decitabine Intravenous-Insulin NPH
- Decitabine Intravenous-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Decitabine Intravenous-Insulin NPH (Vials)
- Decitabine Intravenous-Insulin NPH and Insulin Regular
- Decitabine Intravenous-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Decitabine Intravenous-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-Declomycin
- Insulin lispro Subcutaneous-Decon-A
- Insulin lispro Subcutaneous-Deconamine (Chlorpheniramine and Pseudoephedrine Liquid)
- Insulin lispro Subcutaneous-Deconamine (Chlorpheniramine and Pseudoephedrine Tablets)
- Insulin lispro Subcutaneous-Deconex
- Insulin lispro Subcutaneous-Deconex DMX